EGFR and non-small cell lung carcinoma: Overview of the second set of O-alkylated pyrrolopyrimidine and N-alkylated pyrrolopyrimidin-4-one EGFR inhibitors and corresponding IC50 and EC50 determinations on different EGFR mutant variants and corresponding NSCLC cell linesa